Gujarat Kidney And Super Speciality Limited (GKSL) Share Price
NSE · Healthcare · Medical Care Facilities · ISIN INE0V0W01025
Key metrics
- Market Cap
- ₹1,266 Cr
- P/E Ratio
- 83.17
- EPS
- 1.93
- Book Value
- 32.31
- P/B Ratio
- 4.8
- ROE
- 6.08%
- ROCE
- 7.84%
- Debt / Equity
- 0.11
- Net Margin
- 18.9%
- Revenue Growth
- 103.8%
- Profit Growth
- 64.63%
- Dividend Yield
- —
- 52W High
- ₹163.44
- 52W Low
- ₹98.36
- Market Cap Band
- small cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Gujarat Kidney And Super Speciality Limited
Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limited was founded in 2014 and is headquartered in Vadodara, India.
- Headquarters
- Vadodara, India
- Promoter Holding
- 74.79%
The full Gujarat Kidney And Super Speciality Limited analysis
Create a free account to open the complete GKSL deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.